Fetal Valproate Syndrome

Overview

Journal J Med Genet

Specialty Genetics

Date 1995 Sep 1

PMID 8544193

Citations 45

Authors

J Clayton-Smith

D Donnai

Affiliations

Soon will be listed here.

Citing Articles

Human umbilical cord-derived mesenchymal stem cells alleviate valproate-induced immune stress and social deficiency in rats.

Sun S, Luo S, Chen J, Zhang O, Wu Q, Zeng N Front Psychiatry. 2024; 15:1431689.

PMID: 39238940 PMC: 11375615. DOI: 10.3389/fpsyt.2024.1431689.

Exposure to Valproic-Acid Alters Circadian Organisation and Clock-Gene Expression: Implications for Autism Spectrum Disorders.

Ferraro S, de Zavalia N, Belforte N, Amir S Front Behav Neurosci. 2021; 15:711549.

PMID: 34650409 PMC: 8505722. DOI: 10.3389/fnbeh.2021.711549.

Timing and Intertemporal Choice Behavior in the Valproic Acid Rat Model of Autism Spectrum Disorder.

DeCoteau W, Fox A J Autism Dev Disord. 2021; 52(6):2414-2429.

PMID: 34115327 DOI: 10.1007/s10803-021-05129-y.

Chromatin Imbalance as the Vertex Between Fetal Valproate Syndrome and Chromatinopathies.

Parodi C, Di Fede E, Peron A, Vigano I, Grazioli P, Castiglioni S Front Cell Dev Biol. 2021; 9:654467.

PMID: 33959609 PMC: 8093873. DOI: 10.3389/fcell.2021.654467.

Ion Channel Contributions to Morphological Development: Insights From the Role of Kir2.1 in Bone Development.

Ozekin Y, Isner T, Bates E Front Mol Neurosci. 2020; 13:99.

PMID: 32581710 PMC: 7296152. DOI: 10.3389/fnmol.2020.00099.

References

Dieterich E, Steveling A, Lukas A, Seyfeddinipur N, Spranger J . Congenital anomalies in children of epileptic mothers and fathers. Neuropediatrics. 1980; 11(3):274-83. DOI: 10.1055/s-2008-1071396. View

Dalens B, RAYNAUD E, Gaulme J . Teratogenicity of valproic acid. J Pediatr. 1980; 97(2):332-3. DOI: 10.1016/s0022-3476(80)80517-8. View

Robert E, Rosa F . Valproate and birth defects. Lancet. 1983; 2(8359):1142. DOI: 10.1016/s0140-6736(83)90656-6. View

Mastroiacovo P, Bertollini R, Morandini S, SEGNI G . Maternal epilepsy, valproate exposure, and birth defects. Lancet. 1983; 2(8365-66):1499. DOI: 10.1016/s0140-6736(83)90844-9. View

Felding I, Rane A . Congenital liver damage after treatment of mother with valproic acid and phenytoin?. Acta Paediatr Scand. 1984; 73(4):565-8. DOI: 10.1111/j.1651-2227.1984.tb09974.x. View

DiLiberti J, Farndon P, Dennis N, Curry C . The fetal valproate syndrome. Am J Med Genet. 1984; 19(3):473-81. DOI: 10.1002/ajmg.1320190308. View

Jager-Roman E, Deichl A, Jakob S, Hartmann A, Koch S, Rating D . Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr. 1986; 108(6):997-1004. DOI: 10.1016/s0022-3476(86)80949-0. View

Lindhout D, Schmidt D . In-utero exposure to valproate and neural tube defects. Lancet. 1986; 1(8494):1392-3. DOI: 10.1016/s0140-6736(86)91711-3. View

Huot C, Gauthier M, Lebel M, Larbrisseau A . Congenital malformations associated with maternal use of valproic acid. Can J Neurol Sci. 1987; 14(3):290-3. DOI: 10.1017/s0317167100026639. View

10.

Winter R, Donnai D, Burn J, Tucker S . Fetal valproate syndrome: is there a recognisable phenotype?. J Med Genet. 1987; 24(11):692-5. PMC: 1050348. DOI: 10.1136/jmg.24.11.692. View

11.

Ardinger H, Atkin J, Blackston R, Elsas L, Clarren S, Livingstone S . Verification of the fetal valproate syndrome phenotype. Am J Med Genet. 1988; 29(1):171-85. DOI: 10.1002/ajmg.1320290123. View

12.

ODonoghue P . Relaxation in cerebral palsy. Dev Med Child Neurol. 1988; 30(1):115-7. DOI: 10.1111/j.1469-8749.1988.tb04733.x. View

13.

. Valproate and spina bifida. Lancet. 1989; 1(8638):611-2. View

14.

Chitayat D, Farrell K, Anderson L, Hall J . Congenital abnormalities in two sibs exposed to valproic acid in utero. Am J Med Genet. 1988; 31(2):369-73. DOI: 10.1002/ajmg.1320310214. View

15.

Verloes A, Frikiche A, Gremillet C, Paquay T, Decortis T, Rigo J . Proximal phocomelia and radial ray aplasia in fetal valproic syndrome. Eur J Pediatr. 1990; 149(4):266-7. DOI: 10.1007/BF02106290. View

16.

Martinez-Frias M . Clinical manifestation of prenatal exposure to valproic acid using case reports and epidemiologic information. Am J Med Genet. 1990; 37(2):277-82. DOI: 10.1002/ajmg.1320370224. View

17.

Thisted E, Ebbesen F . Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. Arch Dis Child. 1993; 69(3 Spec No):288-91. PMC: 1029494. DOI: 10.1136/adc.69.3_spec_no.288. View

18.

Van Allen M, Kalousek D, Chernoff G, Juriloff D, Harris M, McGillivray B . Evidence for multi-site closure of the neural tube in humans. Am J Med Genet. 1993; 47(5):723-43. DOI: 10.1002/ajmg.1320470528. View

19.

Sharony R, Garber A, Viskochil D, Schreck R, Platt L, WARD R . Preaxial ray reduction defects as part of valproic acid embryofetopathy. Prenat Diagn. 1993; 13(10):909-18. DOI: 10.1002/pd.1970131005. View

20.

Hanson J, Smith D . The fetal hydantoin syndrome. J Pediatr. 1975; 87(2):285-90. DOI: 10.1016/s0022-3476(75)80604-4. View